Article citationsMore>>

Demircan, N.C., Alan, Ö., Başoğlu Tüylü, T., Akın Telli T, Arıkan R, Çiçek FC, Ercelep Ö, Öztürk MA, Alsan Çetin İ, Ergelen R, Tinay İ, Akgül Babacan N, Kaya S, Dane F. and Yumuk, P.F. (2020) Impact of the Charlson Comorbidity Index on Dose-Limiting Toxicity and Survival in Locally Advanced and Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib or Pazopanib. Journal of Oncology Pharmacy Practice, 26, 1147-1155.
https://doi.org/10.1177/1078155219890032

has been cited by the following article:

• TITLE: Prevalence of Comorbidities in the Urological Patients at the Former Military Teaching Hospital of Cotonou

  AUTHORS: Sossa Jean, Fanou Lionelle, Hounto Yao Félicien, Yevi Dodji Magloire Inès, Hodonou Fred Martin, Avakoudjo Déjinnin Josué Georges

  KEYWORDS: Comorbidity, Urological Patients, Prevalence

  JOURNAL NAME: Open Journal of Urology, Vol.13 No.11, November 6, 2023

  ABSTRACT: Background: Comorbidities are additive diseases and care burdens in urological patients. Determining the epidemiologic profile of comorbidities in urological patients in our setting may help us to better the management of urological disease. Objective: To evaluate the prevalence of comorbidities in urological patients. Patient and Method: We collected comorbidity, urological disease and demographic data in all urological patients managed at the former Military Teaching Hospital of Cotonou from January 1, 2012, to December 31, 2020. We used the software R 4.2.2 to perform descriptive and bi-varied data analysis. Student’s t test was used to compare means. Results: The prevalence of comorbidities was 14.2%, i.e., 601 comorbidity-affected among 4242 patients. The comorbidities predominantly affected men: the sex ratio was 13:1. The presence of comorbidity was correlated with patients’ age (p